| Financial Year |
March 31 2023 |
| Monetary Funds |
1,752,035,967.69 |
| Held-for-trading Financial Assets |
361,804,993.55 |
| Notes Receivable |
-- |
| Accounts Receivable |
132,909,983.15 |
| Advances to Suppliers |
22,473,815.19 |
| Other Receivables |
7,897,790.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
190,302.25 |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
27,241,621.91 |
| Total Current Assets |
2,304,364,172.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
8,483,246,137.10 |
| Investment Properties |
143,957,199.44 |
| Fixed Assetes |
240,868,242.97 |
| Under-construction Projects |
240,817,892.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
60,950,359.93 |
| R&D expenses |
-- |
| Goodwill |
148,844,020.36 |
| Long-Term Deferred and Prepaid Expenses |
39,419,390.47 |
| Deferred Income Tax Assets |
146,314,392.91 |
| Other Non-Current Assets |
761,481.60 |
| Sub-Total of Non-Current Assets |
11,043,480,929.74 |
| Total Assets |
13,347,845,102.13 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
42,132,795.85 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
91,839,739.73 |
| Taxes Payable |
112,121,788.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
21,216,408.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
586,565,859.76 |
| Other Current Liabilities |
167,220,942.67 |
| Sub-Total of Current Liabilities |
1,295,234,606.55 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
415,517.72 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
21,777,054.88 |
| Other Non-Current Liabilities |
10,705,075.72 |
| Sub-Total of Non-Current Liabilities |
85,050,588.38 |
| Total Liabilities |
1,380,285,194.93 |
| Paid-In Capital(Or Share Stock) |
1,542,525,921.44 |
| Capital Surplus |
6,492,418,735.47 |
| Surplus Reserve |
288,752,807.21 |
| LESS:Treasury Stock |
2,521,217,791.85 |
| Undistributed Profits |
6,162,908,917.24 |
| Minority Stockholder's Interest |
45,916,582.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,921,643,324.51 |
| Owner's Equity（Stockholder's Equity） |
11,967,559,907.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,347,845,102.13 |
